Zacks: Analysts Expect SWK Holdings Co. (NASDAQ:SWKH) Will Post Earnings of $0.33 Per Share

Equities research analysts expect that SWK Holdings Co. (NASDAQ:SWKH) will announce earnings of $0.33 per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for SWK’s earnings. SWK posted earnings of $0.31 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 6.5%. The firm is scheduled to report its next earnings report on Monday, August 16th.

On average, analysts expect that SWK will report full-year earnings of $1.54 per share for the current year. For the next year, analysts anticipate that the firm will post earnings of $1.81 per share. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that follow SWK.

SWK (NASDAQ:SWKH) last posted its quarterly earnings data on Sunday, May 16th. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.48 by ($0.11). SWK had a return on equity of 9.63% and a net margin of 34.13%. The company had revenue of $9.37 million during the quarter.

Several research analysts recently weighed in on SWKH shares. Maxim Group restated a “buy” rating and issued a $23.00 price objective on shares of SWK in a research report on Tuesday, April 6th. Zacks Investment Research upgraded shares of SWK from a “strong sell” rating to a “hold” rating in a research report on Wednesday.

Several institutional investors have recently modified their holdings of SWKH. Cannell Capital LLC raised its position in shares of SWK by 13.7% during the 1st quarter. Cannell Capital LLC now owns 751,252 shares of the company’s stock valued at $10,923,000 after acquiring an additional 90,472 shares during the last quarter. M3F Inc. bought a new stake in shares of SWK during the 1st quarter valued at $424,000. BlackRock Inc. raised its position in shares of SWK by 15.6% during the 4th quarter. BlackRock Inc. now owns 173,327 shares of the company’s stock valued at $2,494,000 after acquiring an additional 23,373 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of SWK by 164.9% during the 4th quarter. JPMorgan Chase & Co. now owns 9,902 shares of the company’s stock valued at $143,000 after acquiring an additional 6,164 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of SWK by 159.3% in the 1st quarter. Barclays PLC now owns 2,966 shares of the company’s stock valued at $44,000 after buying an additional 1,822 shares during the period. Institutional investors own 89.28% of the company’s stock.

SWKH stock traded up $0.35 during trading on Thursday, hitting $17.75. The company had a trading volume of 400 shares, compared to its average volume of 40,003. The company has a 50-day simple moving average of $16.98. SWK has a 12 month low of $12.28 and a 12 month high of $18.00. The company has a market cap of $227.20 million, a PE ratio of 17.23, a price-to-earnings-growth ratio of 1.14 and a beta of 0.21.

SWK Company Profile

SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.

Further Reading: How is diluted EPS different from basic EPS?

Get a free copy of the Zacks research report on SWK (SWKH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for SWK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWK and related companies with MarketBeat.com's FREE daily email newsletter.